Literature DB >> 29515683

Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.

Jiri Polivka1,2, Irem Altun3, Olga Golubnitschaja4,5,6.   

Abstract

The paper is motivated by severe concerns regarding currently applied care of the pregnancy-associated breast cancer (PABC) characterised by particularly poor outcomes of the disease. Psychological and ethical aspects play a crucial role in PABC: the highest priority not to damage the foetus significantly complicates any treatment generally, and it is quite usual that patients disclaim undergoing any breast cancer treatment during pregnancy. Although, due to global demographic trends, PABC is far from appearing rarely now, severe societal and economic consequences of the disease are still neglected by currently applied reactive medical approach. These actualities require creating new strategies which should be better adapted to the needs of the society at large by advancing the PABC care based on predictive diagnostic approaches specifically in premenopausal women, innovative screening programmes focused on young female populations, targeted prevention in high-risk groups, and optimised treatment concepts. The article summarises the facts and provides recommendations to advance the field-related research and medical services specifically dedicated to the PABC care.

Entities:  

Keywords:  Breast cancer; Multi-level diagnostics; Predictive preventive personalised medicine; Pregnancy; Recommendations; Risk assessment

Year:  2018        PMID: 29515683      PMCID: PMC5833893          DOI: 10.1007/s13167-018-0129-7

Source DB:  PubMed          Journal:  EPMA J        ISSN: 1878-5077            Impact factor:   6.543


  121 in total

1.  Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  G Pentheroudakis; R Orecchia; H J Hoekstra; N Pavlidis
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

Review 2.  Breast disorders in pregnant and lactating women.

Authors:  Kathryn Faguy
Journal:  Radiol Technol       Date:  2015 Mar-Apr

3.  Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations.

Authors:  Rachel Ballard-Barbash; Sally Hunsberger; Marianne H Alciati; Steven N Blair; Pamela J Goodwin; Anne McTiernan; Rena Wing; Arthur Schatzkin
Journal:  J Natl Cancer Inst       Date:  2009-04-28       Impact factor: 13.506

4.  Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Authors:  Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2011-06-11       Impact factor: 4.872

5.  Cancer incidence in Priolo, Sicily: a spatial approach for estimation of industrial air pollution impact.

Authors:  Lucia Fazzo; Mario Carere; Francesco Tisano; Caterina Bruno; Achille Cernigliaro; Maria Rita Cicero; Pietro Comba; Maria Luisa Contrino; Marco De Santis; Fabrizio Falleni; Vincenzo Ingallinella; Anselmo Madeddu; Ida Marcello; Carlo Regalbuto; Giovanna Sciacca; Maria Eleonora Soggiu; Amerigo Zona
Journal:  Geospat Health       Date:  2016-04-18       Impact factor: 1.212

6.  Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us.

Authors:  Donna Taylor; Joanne Lazberger; Angela Ives; Elizabeth Wylie; Christobel Saunders
Journal:  J Med Imaging Radiat Oncol       Date:  2011-02       Impact factor: 1.735

Review 7.  Breast cancer in pregnancy.

Authors:  Frédéric Amant; Sibylle Loibl; Patrick Neven; Kristel Van Calsteren
Journal:  Lancet       Date:  2012-02-11       Impact factor: 79.321

8.  Cancer incidence in airline cabin crew: experience from Sweden.

Authors:  A Linnersjö; N Hammar; B-G Dammström; M Johansson; H Eliasch
Journal:  Occup Environ Med       Date:  2003-11       Impact factor: 4.402

9.  The impact of pregnancy on breast cancer outcomes in women<or=35 years.

Authors:  Beth M Beadle; Wendy A Woodward; Lavinia P Middleton; Welela Tereffe; Eric A Strom; Jennifer K Litton; Funda Meric-Bernstam; Richard L Theriault; Thomas A Buchholz; George H Perkins
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

10.  Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature.

Authors:  Chuanbo Xie; Wei Wang; Xiuhong Li; Nan Shao; Weidong Li
Journal:  J Matern Fetal Neonatal Med       Date:  2017-11-07
View more
  15 in total

Review 1.  Predictive and individualized management of stroke-success story in Czech Republic.

Authors:  Jiri Polivka; Jiri Polivka; Vladimir Rohan
Journal:  EPMA J       Date:  2018-10-25       Impact factor: 6.543

Review 2.  Current approaches in the clinical management of pregnancy-associated breast cancer-pros and cons.

Authors:  Pavol Zubor; Peter Kubatka; Ivana Kapustova; Lence Miloseva; Zuzana Dankova; Alexandra Gondova; Tibor Bielik; Stefan Krivus; Jan Bujnak; Zuzana Laucekova; Christina Kehrer; Erik Kudela; Jan Danko
Journal:  EPMA J       Date:  2018-06-24       Impact factor: 6.543

3.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

4.  A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicine.

Authors:  Michael J Zellweger; Andrew Tsirkin; Vasily Vasilchenko; Michael Failer; Alexander Dressel; Marcus E Kleber; Peter Ruff; Winfried März
Journal:  EPMA J       Date:  2018-08-16       Impact factor: 6.543

Review 5.  Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention.

Authors:  A Kapinova; P Kubatka; O Golubnitschaja; M Kello; P Zubor; P Solar; M Pec
Journal:  Environ Health Prev Med       Date:  2018-08-09       Impact factor: 3.674

Review 6.  Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management.

Authors:  Pavol Zubor; Peter Kubatka; Karol Kajo; Zuzana Dankova; Hubert Polacek; Tibor Bielik; Erik Kudela; Marek Samec; Alena Liskova; Dominika Vlcakova; Tatiana Kulkovska; Igor Stastny; Veronika Holubekova; Jan Bujnak; Zuzana Laucekova; Dietrich Büsselberg; Mariusz Adamek; Walther Kuhn; Jan Danko; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

7.  Comparing Quality of Life in Breast Cancer Patients Who Underwent Mastectomy Versus Breast-Conserving Surgery: A Meta-Analysis.

Authors:  Elvin T Ng; Russell Z Ang; Bach X Tran; Cyrus S Ho; Zhisong Zhang; Wanqiu Tan; Yu Bai; Min Zhang; Wilson W Tam; Roger C Ho
Journal:  Int J Environ Res Public Health       Date:  2019-12-06       Impact factor: 3.390

Review 8.  Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach.

Authors:  Erik Kudela; Marek Samec; Peter Kubatka; Marcela Nachajova; Zuzana Laucekova; Alena Liskova; Karol Dokus; Kamil Biringer; Denisa Simova; Eva Gabonova; Zuzana Dankova; Kristina Biskupska Bodova; Pavol Zubor; Daniela Trog
Journal:  Cancers (Basel)       Date:  2019-11-14       Impact factor: 6.639

9.  Pregnancy-associated breast cancer in rural Rwanda: the experience of the Butaro Cancer Center of Excellence.

Authors:  Jean Marie Vianney Dusengimana; Vedaste Hategekimana; Ryan Borg; Bethany Hedt-Gauthier; Neil Gupta; Susan Troyan; Lawrence N Shulman; Ignace Nzayisenga; Temidayo Fadelu; Tharcisse Mpunga; Lydia E Pace
Journal:  BMC Cancer       Date:  2018-06-05       Impact factor: 4.430

Review 10.  Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine.

Authors:  Lenka Koklesova; Alena Liskova; Marek Samec; Tawar Qaradakhi; Anthony Zulli; Karel Smejkal; Karol Kajo; Jana Jakubikova; Payam Behzadi; Martin Pec; Pavol Zubor; Kamil Biringer; Taeg Kyu Kwon; Dietrich Büsselberg; Gustavo R Sarria; Frank A Giordano; Olga Golubnitschaja; Peter Kubatka
Journal:  EPMA J       Date:  2020-05-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.